An OM1 Webinar: Exploring Best Practices and Innovation in the New Registry Handbook – 2 Part Series
First published in 2007, the AHRQ publication ...
Top Story
Featured Stories
An OM1 Webinar: Exploring Best Practices and Innovation in the New Registry Handbook - 2 Part Series
First published in 2007, the AHRQ publication "Registries for Evaluating Patient Outcomes: A User's Guide" is among the… Read more
What is the Global Access Impact of COVID-19? DRG and Context Matters Weighs In
Mike Ward, Global Head of Thought Leadership at Decision Resources Group talks with Steve Edgar of DRG Global Market… Read more
Virtual ISPOR-FDA Summit 2020 Program Announced | September 29
Virtual ISPOR-FDA Summit 2020, jointly sponsored by ISPOR and the US Food and Drug Administration (FDA) Center for… Read more
Latest Stories
An OM1 Webinar: Exploring Best Practices and Innovation in the New Registry Handbook – 2 Part Series
First published in 2007, the AHRQ publication "Registries for Evaluating Patient Outcomes: A User's Guide" is among the most cited texts on the subject of patient registries. This well-respected reference handbook provides practical information on the design, operation, and analysis of patient […]
What is the Global Access Impact of COVID-19? DRG and Context Matters Weighs In
Mike Ward, Global Head of Thought Leadership at Decision Resources Group talks with Steve Edgar of DRG Global Market Access and Judith Rubinstein, Senior Director of Market Access Data with Context Matters, a Decision Resources Group company. In this video conversation, hear insights about how […]
Virtual ISPOR-FDA Summit 2020 Program Announced | September 29
Virtual ISPOR-FDA Summit 2020, jointly sponsored by ISPOR and the US Food and Drug Administration (FDA) Center for Devices and Radiological Health (CDRH), has been redesigned to a full virtual event scheduled for September 29. The Summit will provide a forum to engage a variety of healthcare […]
Flatiron Health Collaborates with NICE on RWE for CEA
Flatiron Health, a healthcare technology company focused on cancer research and part of Roche, partnered with NICE to explore how real-world evidence (RWE) can inform the clinical and cost-effectiveness of health technologies. Together, Flatiron Health and NICE will conduct research using data from […]
CMS Issues Lowest Part D Premium Since 2013: AHIP Warns Rebate Rule Could Impact This
CMS has announced the average basic Part D premium for 2021 will be $30.50. This presents a slight uptick from the 2020 average basic Part D premium when premiums were around $30. Premium savings over the past three years have amounted to $1.9 billion, according to CMS, and savings are due to […]
Podcast: Will Patients See Lower Rx Prices, from Trump’s Executive Order?
The latest Patients Rising Podcast features Terry and Bob discussing policies such as co-pay accumulators and rebates, while Katy Talento (former lead health advisor to President Trump) breaks down how the recent Executive Orders to lower prescription drug prices will actually impact patients. Hear […]
The Cost Argument: Requiring Masks for COVID-19
Patients Rising, a national nonprofit organization dedicated to providing support and education to people with chronic and life-threatening illnesses, summarizes the "wear a mask" debate in the United States. A natural study out of the University of Iowa evidenced that the implementation of mask […]
New Value & Outcomes Spotlight Editors Take the Helm
New Editors-in-Chief were recently appointed for Value & Outcomes Spotlight. Zeba M. Khan, RPh, PhD and Laura T. Pizzi, PharmD, MPH will steer the editorial direction of the publication and develop engaging content that will resonate with both HEOR expert and nonexpert audiences around the […]
ISPOR Europe 2020 Is Now Virtual | 14-18 November
Virtual ISPOR Europe 2020, “Improving Health: Establishing Incentives and Sharing Value,” will now be held as a completely virtual conference. Content for Virtual ISPOR Europe 2020 will be delivered both synchronously and asynchronously, through live and on-demand sessions released leading up to the […]
ISPOR’s CSO Dr. Lucinda Orsini shares views on use of RWE by regulators and HTAs
In this interview with Lucinda Orsini, D.P.M., M.P.H., the Associate Chief Science Officer for the Professional Society for Health Economics and Outcomes Research (ISPOR), she shares her views on navigating the opportunities and challenges of working with RWE. Dr. Orsini sees substantial […]
